Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis.

Hawkins N, Hazra A, Brizzi M, Thompson J, Grove R, Sieverding M, Budnik P, Scherzer J, Danchenko N, Anderson SJ, Dupont-Benjamin L

Open source

DOI: 10.1007/s12325-026-03591-7
Published: 2026 Aug
Container: Advances in therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s12325-026-03591-7,
  title = {Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis.},
  author = {Hawkins N and Hazra A and Brizzi M and Thompson J and Grove R and Sieverding M and Budnik P and Scherzer J and Danchenko N and Anderson SJ and Dupont-Benjamin L},
  year = {2026},
  journal = {Advances in therapy},
  doi = {10.1007/s12325-026-03591-7},
  url = {https://doi.org/10.1007/s12325-026-03591-7}
}

RIS

TY  - JOUR
TI  - Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis.
AU  - Hawkins N
AU  - Hazra A
AU  - Brizzi M
AU  - Thompson J
AU  - Grove R
AU  - Sieverding M
AU  - Budnik P
AU  - Scherzer J
AU  - Danchenko N
AU  - Anderson SJ
AU  - Dupont-Benjamin L
PY  - 2026
JO  - Advances in therapy
DO  - 10.1007/s12325-026-03591-7
UR  - https://doi.org/10.1007/s12325-026-03591-7
ER  -

APA

N, H., A, H., M, B., J, T., R, G., M, S., P, B., J, S., N, D., SJ, A., & L, D. (2026). Indirect Treatment Comparison of the Efficacy of Long-Acting Injectable Cabotegravir Compared With Lenacapavir for HIV Pre-exposure Prophylaxis.. Advances in therapy. https://doi.org/10.1007/s12325-026-03591-7

Source records

pubmed · retrieved 2026-09-25T19:24:15.047Z